Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Alzheimer's and Neurodegenerative Diseases

  • You have access
    [18F]FMS-IMPY and [18F]FES-IMPY as potential radioligands for imaging brain beta-amyloid
    Lisheng Cai, Jeih-San Liow, Cheryl Morse, Nick Seneca, Sebastian Temme, Saumil Sheth, Robert Gladding, Robert Innis and Victor Pike
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 130P;
  • You have access
    Imaging plaques in animal models of AD using nanoparticles encapsulated with radioiodinated clioquinol
    P. Kulkarni, C. Roney, V. Arora, M. Bennett, D. Russell, P. Fuchs, C. White, P. Antich and F. Bonte
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 130P;
  • You have access
    Evaluation of a new imaging agent for central nicotinic acetylcholine receptor α7 subtype
    Mikako Ogawa, Hideo Tsukada, Kentaro Hatano, Hiroshi Yamaguchi, Junichiro Abe, Shingo Nishiyama, Takeharu Kakiuchi, Hiroyuki Oba, Norihiro Harada, Yoshitaka Matsushima, Takeshi Fuchigami, Kengo Ito and Yasuhiro Magata
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 128P;
  • You have access
    Feasibility of using radiofluorinated perisynaptic calcium channel ligands to image early neurodegeneration
    Nwe Linn Htet, Justine Pomakian, Harry Vinters, Johannes Czernin, Michael Phelps and Daniel Silverman
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 129P;
  • You have access
    [I-131]-3-Iodocytisine: Synthesis and biodistribution of a new receptor ligand for in-vivo imaging of nicotinic acetylcholine receptors
    Stefan Guhlke, Julia Paulikt, Ullrich Wuellner, Daniela Guendisch, Hans Biersack and Joern Schmaljohann
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 129P;
  • You have access
    SPECT imaging with a new nicotinic acetylcholinergic antagonist [123I]MNI-201 in baboon
    Gilles Tamagnan, Andrei Koren, David Alagille, Julie Staley, Ivy Carroll and John Seibyl
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 129P;
  • You have access
    Bisphenyltriazoles as potential imaging agents for Alzheimer’s disease
    Wenchao Qu, Mei-Ping Kung, Catherine Hou and Hank Kung
    Journal of Nuclear Medicine May 1, 2007, 48 (supplement 2) 129P;
SNMMI

© 2025 SNMMI

Powered by HighWire